Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procalcitonin-guided versus conventional antibiotic therapy for sepsis in ICU patients
NL-OMON33222Withdrawn
- Sponsor
- Alysis Zorggroep
- Start
- Sep 2009
- Countries
- 1
01
Overview
Open-label trial in sepsis and bloodstream infection (BSI) (2 arms), sponsored by Alysis Zorggroep. Primary endpoints: Duration of antibiotic therapy and Antibiotic-free days. Planned start Sep 2009; status: withdrawn.
02
Conditions
sepsisbloodstream infection (BSI)
Beyond the preview
Go deeper on NL-OMON33222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33222.